PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.\', \'Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA; Viral and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Department of Family Medicine, for Stanley Herring Department of Physical Medicine and Rehabilitation, University of Washington, Seattle, Washington, USA.\', \'Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA; Viral and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: agrening@uw.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1386-6532(21)00167-010.1016/j.jcv.2021.104900
?:hasPublicationType
?:journal
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
is ?:pmid of
?:pmid
?:pmid
  • 34171548
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all